comparemela.com

Orphan Drug News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Tafenoquine Gets Orphan Drug Status for Acute Babesiosis

Babesiosis is an infectious disease caused by microscopic parasites, Babesia, that infect red blood cells.

United statesTufts medical centerGeoff dowDrug administrationDegrees pharmaceuticalsOrphan drug

Osteal Therapeutics Closes $50M Series D Financing to Support Approval and Commercial Launch of Lead Candidate

BioPharma

United statesDavid thompsonZimmer biometJjdc incOsteal therapeutics incJohnson innovationGideon strategic partnersOsteal therapeuticsNew drug applicationOrphan drugFast trackQualified infectious disease productChief executivePeriprosthetic joint infection

Novel Antifibrotic Gets Orphan Drug Status for Idiopathic Pulmonary Fibrosis

The FDA has granted Orphan Drug designation to AGMB-447 for the treatment of idiopathic pulmonary fibrosis.

Philippe wieselDrug administrationOrphan drugChief medical officer

Engineered B Cell Medicine Gets Orphan Drug Status for Hemophilia B

BE-101 is a potential first-in-class B cell medicine engineered to insert the human FIX gene into primary human B cells.

Joanne smith farrellDrug administrationOrphan drug

Functional Improvement Seen With C1q Inhibitor in Guillain-Barré Syndrome

ANX005 is a C1q inhibitor that is administered intravenously and works by blocking the activation of classical complement pathway.

International guillain barrDrug administrationResearch councilPeripheral nerve society annual meeting onMedical research councilDouglas loveWestern international guillain barrSyndrome outcomes studyBiologics license applicationNerve society annual meetingFast trackOrphan drug

vimarsana © 2020. All Rights Reserved.